Posted in | News

Skanska Secures New Groundwater Treatment Plant Construction Assignment

Skanska (STO:SKAB) is to lead the construction of a groundwater treatment plant in Hanford, in Washington State in the U.S. The contract amounts to USD 50 M, approximately SEK 360 M, and will be included in order bookings for the second quarter.

The customer is CH2M HILL, a company active within the energy, chemicals and environmental sectors. The project is to receive support from the U.S. government stimulus package, the American Recovery and Reinvestment Act.

Skanska secured the assignment based on an overall valuation of price, technical expertise and its track record in green construction and safety.

The new plant will be constructed with the aim of meeting the demands for Gold-level certification in accordance with the international LEED environmental system. To date, Skanska has built more than 100 projects that have received or applied for LEED certification.

The project comprises an approximately 5,000 square-meter operations and processing building, 200 West Groundwater Treatment System, for groundwater treatment. The finished plant, with a capacity of 7.6 cubic meters per minute, will treat groundwater containing radioactive and biological contaminants. After processing, the groundwater will be of drinking water standard in order to prevent leakage of contaminants into the nearby Columbia River.

Work on the site will commence in the summer and will be completed in 2011. The construction management assignment will be conducted by Skanska USA Building’s office in Seattle, Washington.

Source: http://www.skanska.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.